Diverse regulation of full-length and truncated growth hormone receptor expression in 3T3-L1 adipocytes

Molecular and Cellular Endocrinology

Volumn 210, Issue 1-2, 2003, Pages 21-29

  Iida, Keiji ^a   Takahashi, Yutaka ^a   Kaji, Hidesuke ^b   Yoshioka, Shiro ^a   Murata, Masahiro ^a   Iguchi, Genzo ^a   Okimura, Yasuhiko ^c   Chihara, Kazuo ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Department of Physiology and Biochemistry   (Japan)

^c KOBE UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

3T3 L1 adipocyte; Dominant negative effect; Growth hormone receptor; Isoform; Regulation; Truncated form

Indexed keywords

GROWTH HORMONE; GROWTH HORMONE RECEPTOR; MESSENGER RNA; PROTEIN SUBUNIT; SOMATOMEDIN;

ADIPOCYTE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL MATURATION; CELL STIMULATION; CELL STRAIN 3T3; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE ACTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 0242495022     PISSN: 03037207     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mce.2003.08.006     Document Type: Article

References (22)

1. Ayling R.M., Ross R., Towner P., Von Laue S., Finidori J., Moutoussamy S., Buchanan C.R., Clayton P.E., Norman M.R. A dominant-negative mutation of the growth hormone receptor causes familial short stature. Nat. Genet. 16:1997;13-14.
2. Ballesteros M., Leung K.C., Ross R.J., Iismaa T.P., Ho K.K. Distribution and abundance of messenger ribonucleic acid for growth hormone receptor isoforms in human tissues. J. Clin. Endocrinol. Metab. 85:2000;2865-2871.
3. Bernlohr D.A., Angus C.W., Lane M.D., Bolanowski M.A., Kelly T.J. Jr. Expression of specific mRNAs during adipose differentiation: identification of an mRNA encoding a homologue of myelin P2 protein. Proc. Natl. Acad. Sci. U.S.A. 81:1984;5468-5472.
4. Dastot F., Sobrier M.L., Duquesnoy P., Duriez B., Goossens M., Amselem S. Alternatively spliced forms in the cytoplasmic domain of the human growth hormone (GH) receptor regulate its ability to generate a soluble GH-binding protein. Proc. Natl. Acad. Sci. U.S.A. 93:1996;10723-10728.
5. Dastot F., Duquesnoy P., Sobrier M.L., Goossens M., Amselem S. Evolutionary divergence of the truncated growth hormone receptor isoform in its ability to generate a soluble growth hormone binding protein. Mol. Cell. Endocrinol. 137:1998;79-84.
6. Edens A., Talamantes F. Alternative processing of growth hormone receptor transcripts. Endocr. Rev. 19:1998;559-582.
7. Fisker S., Kristensen K., Rosenfalck A.M., Pedersen S.B., Ebdrup L., Richelsen B., Hilsted J., Christiansen J.S., Jorgensen J.O. Gene expression of a truncated and the full-length growth hormone (GH) receptor in subcutaneous fat and skeletal muscle in GH-deficient adults: impact of GH treatment. J. Clin. Endocrinol. Metab. 86:2001;792-796.
8. Green H., Kehinde O. Sublines of mouse 3T3 cells that accumulate lipid. Cell. 1:1974;113-116.
9. Iida K., Takahashi Y., Kaji H., Nose O., Okimura Y., Abe H., Chihara K. Growth hormone (GH) insensitivity syndrome with high serum GH-binding protein levels caused by a heterozygous splice site mutation of the GH receptor gene producing a lack of intracellular domain. J. Clin. Endocrinol. Metab. 83:1998;531-537.
10. Iida K., Takahashi Y., Kaji H., Takahashi M.O., Okimura Y., Nose O., Abe H., Chihara K. Functional characterization of truncated growth hormone (GH) receptor-(1-277) causing partial GH insensitivity syndrome with high GH-binding protein. J. Clin. Endocrinol. Metab. 84:1999;1011-1016.
11. Kamel A., Margery V., Norstedt G., Thoren M., Lindgren A.C., Bronnegard M., Marcus C. Growth hormone (GH) treatment up-regulates GH receptor mRNA levels in adipocytes from patients with GH deficiency and Prader-Willi syndrome. Pediatr. Res. 38:1995;418-421.
12. Leung D.W., Spencer S.A., Cachianes G., Hammonds R.G., Collins C., Henzel W.J., Barnard R., Waters M.J., Wood W.I. Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature. 330:1987;537-543.
13. Morikawa M., Nixon T., Green H. Growth hormone and the adipose conversion of 3T3 cells. Cell. 29:1982;783-789.
14. Rentsch J., Chiesi M. Regulation of ob gene mRNA levels in cultured adipocytes. FEBS Lett. 379:1996;55-59.
15. Richelsen B. Action of growth hormone in adipose tissue. Horm. Res. 48(Suppl. 5):1997;105-110.
16. Rodriguez-Arnao J., Jabbar A., Fulcher K., Besser G.M., Ross R.J. Effects of growth hormone replacement on physical performance and body composition in GH deficient adults. Clin. Endocrinol. (Oxford). 51:1999;53-60.
17. Ross R.J., Esposito N., Shen X.Y., Von Laue S., Chew S.L., Dobson P.R., Postel-Vinay M.C., Finidori J. A short isoform of the human growth hormone receptor functions as a dominant negative inhibitor of the full-length receptor and generates large amounts of binding protein. Mol. Endocrinol. 11:1997;265-273.
18. Siebert P.D., Larrick J.W. Competitive PCR. Nature. 359:1992;557-558.
19. Sumantran V.N., Tsai M.L., Schwartz J. Growth hormone induces c-fos and c-jun expression in cells with varying requirements for differentiation. Endocrinology. 130:1992;2016-2024.
20. Vottero A., Kimchi-Sarfaty C., Kratzsch J., Miller G., Lafferty A., Chrous G.P., Hochberg Z. Relative abundance of growth hormone receptor isoforms in rhesus monkey tissues and human transformed lymphocytes. Horm. Metab. Res. 35:2003a;1-6.
21. Vottero A., Kimchi-Sarfaty C., Kratzsch J., Chrous G.P., Hochberg Z. Transcriptional and translational regulation of the splicing isoforms of the growth hormone receptor by glucocorticoids. Horm. Metab. Res. 35:2003b;7-12.
22. Zou L., Menon R.K., Sperling M.A. Induction of mRNAs for the growth hormone receptor gene during mouse 3T3-L1 preadipocyte differentiation. Metabolism. 46:1997;114-118.